ArticleKorean circulation journal2024

Lower Atrial Fibrillation Risk With Sodium-Glucose Cotransporter 2 Inhibitors Than With Dipeptidyl Peptidase-4 Inhibitors in Individuals With Type 2 Diabetes: A Nationwide Cohort Study.

Min Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.